Rani Therapeutics Holdings, Inc.
RANI
$1.05
-$0.05-4.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.18% | 20.21% | 1.66% | 2.93% | -26.05% |
| Total Depreciation and Amortization | -30.08% | -13.90% | -5.88% | 1.21% | 17.18% |
| Total Amortization of Deferred Charges | -43.10% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 300.55% | 125.47% | 76.39% | 63.93% | 141.12% |
| Change in Net Operating Assets | 627.74% | 60.37% | 1,401.23% | -97.59% | 62.14% |
| Cash from Operations | 103.40% | 39.80% | 35.81% | 13.33% | 30.64% |
| Capital Expenditure | 100.00% | 100.00% | 60.64% | -183.33% | 81.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,313.64% | -100.00% | -13.13% | 77.27% | -81.01% |
| Cash from Investing | -1,328.56% | -100.00% | -12.44% | 77.08% | -81.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -152.59% | -200.00% | -- | -- | -- |
| Issuance of Common Stock | 1,029.79% | -70.88% | 2,291.52% | -65.29% | 10,315.63% |
| Repurchase of Common Stock | -133.33% | 50.00% | 66.67% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -588.89% | 83.08% | -- | -- | -- |
| Cash from Financing | 698.22% | -113.10% | 33.33% | -3,183.47% | 5,753.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,852.23% | -2,462.03% | 104.44% | 526.75% | -157.74% |